Adverse cardiac events to monoclonal antibodies used for cancer therapy: The risk of Kounis syndrome

OncoImmunology

Volumn 3, Issue 2, 2014, Pages

  Kounis, Nicholas G ^a   Soufras, George D ^b   Tsigkas, Grigorios ^c   Hahalis, George ^c  

^a Patras Highest Institute of Education and Technology   (Greece)

^b UNIVERSITY GENERAL HOSPITAL OF PATRAS   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

Cancer therapy; Cardiac hypersensitivity; Cardiac toxicity; Kounis syndrome; Monoclonal antibodies

Indexed keywords

ALEMTUZUMAB; BEVACIZUMAB; CAPECITABINE; CETUXIMAB; GLYCERYL TRINITRATE; MONOCLONAL ANTIBODY; NAVELBINE; PERTUZUMAB; RANIBIZUMAB; RITUXIMAB; TRASTUZUMAB;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADVERSE OUTCOME; ALLERGIC REACTION; ANAPHYLAXIS; ANGINA PECTORIS; ARM PAIN; ARTERIAL THROMBOEMBOLISM; ARTICLE; BLEEDING; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CARDIOMYOPATHY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHILL; COLON CANCER; COLORECTAL CANCER; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG MONITORING; DRUG RESEARCH; DYSPNEA; ERYTHEMA; FEVER; HAIRY CELL LEUKEMIA; HEART ARREST; HEART ARRHYTHMIA; HEART INFARCTION; HEART LEFT ANTERIOR BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE FAILURE; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE FAILURE; HUMAN; HYPERHIDROSIS; HYPERSENSITIVITY; HYPOTENSION; KOUNIS SYNDROME; LIVER METASTASIS; LUNG METASTASIS; MYOCARDIAL DISEASE; NAUSEA; NOMENCLATURE; PATHOPHYSIOLOGY; PHOTODYNAMIC THERAPY; PRECORDIAL PAIN; PRURITUS; RETINA MACULA AGE RELATED DEGENERATION; RHEUMATOID ARTHRITIS; SUDDEN CARDIAC DEATH; T CELL LYMPHOMA; THORAX PAIN; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; VOMITING; WOUND HEALING IMPAIRMENT;

EID: 84899048382     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.27987     Document Type: Article

References (16)

1. Kounis NG. Coronary hypersensitivity disorder: the Kounis syndrome. Clin Ther 2013; 35:563-71; PMID:23490289; http://dx.doi.org/10.1016/j. clinthera.2013.02.022.
2. Simpson A, Soderstrom L, Ahlstedt S, Murray CS, Woodcock A, Custovic A. IgE antibody quantification and the probability of wheeze in preschool children. J Allergy ClinImmunol 2005; 116:744-9; PMID:16210045; http://dx.doi.org/10.1016/j. jaci.2005.06.032.
3. Hasegawa S, Tashiro N, Matsubara T, Furukawa S, Ra C. A comparison of FcepsilonRI-mediated RANTES release from human platelets between allergic patients and healthy individuals. Int Arch Allergy Immunol 2001; 125(Suppl 1):42-7; PMID:11408772; http://dx.doi. org/10.1159/000053852.
4. Baldo BA. Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses. Oncoimmunology 2013; 2:e26333; PMID:24251081; http://dx.doi.org/10.4161/onci.26333.
5. Gori T, Münzel T. A case of coronary hypersensitivity (Kounis) syndrome associated with mid-ventricular ballooning pattern, intracoronary thrombosis and troponin elevation. Int J Cardiol 2011; 149:377-8; PMID:21420182; http://dx.doi.org/10.1016/j. ijcard.2011.02.066.
6. Arunprasath P, Gobu P, Dubashi B, Satheesh S, Balachander J. Rituximab induced myocardial infarction: A fatal drug reaction. J Cancer Res Ther 2011; 7:346-8; PMID:22044821; http://dx.doi. org/10.4103/0973-1482.87003.
7. Armitage JD, Montero C, Benner A, Armitage JO, Bociek G. Acute coronary syndromes complicating the first infusion of rituximab. Clin Lymphoma Myeloma 2008; 8:253-5; PMID:18765315; http://dx.doi.org/10.3816/CLM.2008.n.035.
8. Vultaggio A, Matucci A, Nencini F, Pratesi S, Petroni G, Cammelli D, Alterini R, Rigacci L, Romagnani S, Maggi E. Drug-specific Th2 cells and IgE antibodies in a patient with anaphylaxis to rituximab. Int Arch Allergy Immunol 2012; 159:321-6; PMID:22846615; http://dx.doi.org/10.1159/000336839.
9. vanSijl AM, van der Weele W, Nurmohamed MT. Myocardial Infarction after Rituximab Treatment for Rheumatoid Arthritis: Is there a Link? Curr Pharm Des 2013; Forthcoming; PMID:23565629.
10. Shibahara H, Kuze S, Kyokane T, Takamizawa J, Nakamura H, Morikawa S, Hayashi E, Kinoshita M, Baba S. [A case of recurrent colon cancer with angina pectoris and interstitial pneumonia during cetuximab therapy with death by carcinomatous lymphangiosis] [article in Japanese]. Gan To Kagaku Ryoho 2010; 37:2193-8; PMID:21084826.
11. Damaj G, Rubio MT, Audard V, Hermine O. Severe cardiac toxicity after monoclonal antibody therapy.Eur J Haematol 2002; 68:324; PMID:12144543; http://dx.doi.org/10.1034/j.1600-0609.2002.00712.x.
12. Okada Y, Okura Y, Takii Y. [Two cases of unstable angina in patients treated with bevacizumab][article in Japanese]. Gan To Kagaku Ryoho 2010; 37:1405-8; PMID:20647738.
13. Kemp A, Preen DB, Morlet N, Clark A, McAllister IL, Briffa T, Sanfilippo FM, Ng JQ, McKnight C, Reynolds W, et al. Myocardial infarction after intravitreal vascular endothelial growth factor inhibitors: a whole population study. Retina 2013; 33:920-7; PMID:23492942; http://dx.doi. org/10.1097/IAE.0b013e318276e07b.
14. Carneiro AM, Barthelmes D, Falcão MS, Mendonça LS, Fonseca SL, Gonçalves RM, Faria-Correia F, Falcão-Reis FM. Arterial thromboembolic events in patients with exudative age-related macular degeneration treated with intravitrealbevacizumab or ranibizumab. Ophthalmologica 2011; 225:211-21; PMID:21336001; http://dx.doi. org/10.1159/000323943.
15. Chen MH. Cardiac dysfunction induced by novel targeted anticancer therapy: an emerging issue. CurrCardiol Rep 2009; 11:167-74; PMID:19379636; http://dx.doi.org/10.1007/s11886-009-0025-9.
16. Le Brun-Ly V, Martin J, Venat-Bouvet L, Darodes N, Labourey JL, Genet D, Tubiana-Mathieu N. Cardiac toxicity with capecitabine, vinorelbine and trastuzumab therapy: case report and review of fluoropyrimidine-related cardiotoxicity. Oncology 2009; 76:322-5; PMID:19307737; http://dx.doi.org/10.1159/000209336.